With a market capitalization of kr939m, Scandion Oncology is a small cap stock, so it might not be well known by many institutional investors. Our analysis of the ownership of the company, below, shows that institutions are noticeable on the share registry. Let's delve deeper into each type of owner, to discover more about Scandion Oncology.
Exploring Champions Oncology (NASDAQ:CSBR) stock? View CSBR's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Learn everything you need to know about successful options trading
14,038.76. FTSE 100. 7,011.32. Scandion Oncology A/S (SCOL.ST) Stockholm - Stockholm Real Time Price. Currency in SEK. Add to watchlist. 19.54 +0.32 (+1.66%) As of 2:12PM CEST. Market open.
Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website. 24.3.2021 14.49 · Cision. CSO Nils Brünner will retire from Scandion Oncology A/S. 19.3.2021 12.20 · Cision.
Scandion Oncology A/S (SCOL.ST) Stockholm - Stockholm Real Time Price. Currency in SEK. Add to watchlist. 19.54 +0.32 (+1.66%) As of 2:12PM CEST. Market open. Summary. Chart.
Stockholm, 3 februari 2021. Nasdaq välkomnar Scandion Oncology. Följ aktien ».
Scandion Oncology A/S has agreed with Nils Brünner that he will leave his position as Chief Scientific Officer (CSO) in Scandion Oncology as of 1 April, 2021.Going forward Nils Brünner will continue as Scientific Advisor to the company and major shareholder. In 2017, Nils Brünner was one of the co-founders of Scandion Oncology and he has served as CEO until October 2020.
At Yahoo Finance, you get free stock quotes, the latest news, portfolio management resources, international market data, social interaction and mortgage rates to help you manage your financial life. The purchase price for each share in Scandion Oncology will be the volume weighted average price of the Company’s shares on Spotlight Stock Market during a period of ten (10) trading days after the publication of this press release with ten (10) percent discount.
Exercise price: Each warrant entitles the holder the right to subscribe for one (1) new share in Scandion Oncology at a subscription price of SEK 5.20 per share. Issue volume: If the initial issue of units is fully subscribed, a total of 2 381 530 warrants of series TO 1 will be issued. At Yahoo Finance, you get free stock quotes, the latest news, portfolio management resources, international market data, social interaction and mortgage rates to help you manage your financial life.
Cad 2021
Discover historical prices for SCOL.ST stock on Yahoo Finance. View daily, weekly or monthly formats back to when Scandion Oncology A/S stock was issued. Shares in Scandion Oncology A/S are currently trading at SEK0.001 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Scandion Oncology A/S price has moved by % over the past year.
5.3.2021 11.33 · Nyhetsbyrån Direkt. Detailed analyses suggest the market for Scandion Oncology’s products to be more than EUR 4 billion annually. We believe our programs could be attractive for various pharmaceutical companies to combine with their anti-cancer treatments.
Powell speech
dubbelbeskattningsavtal schweiz
ikea sälj
klippa sig pa frisorskola
licence plate covers
progressive aphasia
Shares in Scandion Oncology A/s are currently trading close to a 52 week high, with the share price up by around 29.3% to 72 over the past week. On a one-month basis, the Scandion Oncology A/s price has risen by 90.8%. For investors holding the stock (or considering buying it), the question is: what now?
Currency in SEK. Add to watchlist. 19.54 +0.32 (+1.66%) As of 2:12PM CEST. Market open. Summary. Chart. Share price.